ClinConnect ClinConnect Logo
Search / Trial NCT05795504

Resistive Exercise Versus HIIT on Calcium and Vitamin D

Launched by CAIRO UNIVERSITY · Mar 21, 2023

Trial Information

Current as of November 06, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is testing whether adding two types of exercise to vitamin D and calcium supplements can better improve vitamin D and calcium levels in premenopausal women who have low vitamin D and low calcium intake. Participants are randomly assigned to one of three groups for about 12 weeks: (1) resistive (strength) exercise plus calcium and vitamin D, (2) high‑intensity interval training (HIIT) plus calcium and vitamin D, or (3) calcium and vitamin D supplements alone. Researchers will take blood tests at the start and after about three months to measure vitamin D and calcium levels. Results are not yet available because the trial is ongoing.

Who can join? The study is for adult women aged 40–45 who are premenopausal, have a BMI between 25 and 30, a vitamin D level in the deficient range (about 12–19 ng/mL), and low calcium intake (less than roughly 500 mg per day). Key exclusions include smoking, serious health problems (like uncontrolled blood pressure or diabetes), osteoporosis, or current hormone replacement therapy. The trial is being conducted at the Cairo University Faculty of Physical Therapy in Giza, Egypt, and plans to enroll about 60 participants, with enrollment by invitation.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Premenopausal women having reduced calcium level (less than 500mg) intake as recorded by 24 hours' dietary recall method and vitamin D deficiency (12-19 ng/ml).
  • Their ages will range from 40 to 45 years.
  • Their BMI will range from 25-30 kg/m2.
  • Don't receive hormonal replacement therapy.
  • Exclusion Criteria:
  • Smoking.
  • History of chronic disease (uncontrolled hypertension, diabetes mellitus)
  • Osteoporosis.
  • severe musculoskeletal disorders
  • cardiovascular disease, thyroid dysfunction

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Giza, Egypt

Patients applied

0 patients applied

Trial Officials

Mai shehata

Principal Investigator

faculty of physical therapy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials